These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 35403371)

  • 1. Characteristics of HIV post-exposure prophylaxis recipients at six English sexual health clinics during COVID-19.
    Whitlock GG; Ahmed N; Nori A; Richardson D; Clarke E; Browne R; Doctor J; Williams A; Parkhouse A; Clouser O; Thornhill J
    HIV Med; 2022 Nov; 23(10):1103-1107. PubMed ID: 35403371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing HIV Post-Exposure Prophylaxis, Testing, and New Diagnoses in Two Australian Cities with Different Lockdown Measures during the COVID-19 Pandemic.
    Chow EPF; Ong JJ; Donovan B; Foster R; Phillips TR; McNulty A; Fairley CK
    Int J Environ Res Public Health; 2021 Oct; 18(20):. PubMed ID: 34682556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of COVID-19 pandemic on provision of sexual and reproductive health services in primary health facilities in Nigeria: a cross-sectional study.
    Adelekan B; Goldson E; Abubakar Z; Mueller U; Alayande A; Ojogun T; Ntoimo L; Williams B; Muhammed I; Okonofua F
    Reprod Health; 2021 Aug; 18(1):166. PubMed ID: 34348757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Young people's access to sexual and reproductive health prevention services in South Africa during the COVID-19 pandemic: an online questionnaire.
    Baker V; Mulwa S; Khanyile D; Sarrassat S; O'Donnell D; Piot S; Diogo Y; Arnold G; Cousens S; Cawood C; Birdthistle I
    BMJ Paediatr Open; 2023 Jan; 7(1):. PubMed ID: 36693683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 restrictions and changing sexual behaviours in HIV-negative MSM at high risk of HIV infection in London, UK.
    Hyndman I; Nugent D; Whitlock GG; McOwan A; Girometti N
    Sex Transm Infect; 2021 Nov; 97(7):521-524. PubMed ID: 33462118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-retroviral Therapy Based HIV Prevention Among a Sample of Men Who Have Sex with Men in Cape Town, South Africa: Use of Post-exposure Prophylaxis and Knowledge on Pre-exposure Prophylaxis.
    Hugo JM; Stall RD; Rebe K; Egan JE; De Swardt G; Struthers H; McIntyre JA
    AIDS Behav; 2016 Dec; 20(Suppl 3):357-364. PubMed ID: 27631366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in mental and sexual health among MSM using HIV pre-exposure prophylaxis during the SARS-CoV-2 pandemic: longitudinal analysis of the SwissPrEPared cohort study.
    Winter BL; Hovaguimian F; Kouyos RD; Schmidt AJ; Bernasconi E; Braun DL; Calmy A; Notter J; Stoeckle M; Surial B; Christinet V; Cavassini M; Depmeier C; Läuchli S; Boffi El Amari E; Reinacher M; Rasi M; Bruggmann P; Haerry D; Bize R; Low N; Lehner A; Quednow BB; Fehr JS; Hampel B
    Swiss Med Wkly; 2022 Jun; 152():w30192. PubMed ID: 35758418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. To prescribe, or not to prescribe: decision making in HIV-1 post-exposure prophylaxis.
    Scholten M; Suárez I; Platten M; Kümmerle T; Jung N; Wyen C; Ernst A; Horn C; Burst V; Suárez V; Rybniker J; Fätkenheuer G; Lehmann C
    HIV Med; 2018 Oct; 19(9):645-653. PubMed ID: 29993176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake and outcomes of a novel community-based HIV post-exposure prophylaxis (PEP) programme in rural Kenya and Uganda.
    Ayieko J; Petersen ML; Kabami J; Mwangwa F; Opel F; Nyabuti M; Charlebois ED; Peng J; Koss CA; Balzer LB; Chamie G; Bukusi EA; Kamya MR; Havlir DV
    J Int AIDS Soc; 2021 Jun; 24(6):e25670. PubMed ID: 34152067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV Post-Exposure Prophylaxis (PEP) Awareness and Non-Occupational PEP (nPEP) Prescribing History Among U.S. Healthcare Providers.
    John SA; Quinn KG; Pleuhs B; Walsh JL; Petroll AE
    AIDS Behav; 2020 Nov; 24(11):3124-3131. PubMed ID: 32300991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does dropping day 5 PEP follow-up affect outcomes? An audit of HIV post-exposure prophylaxis at a central London sexual health clinic.
    O'Keeffe C; Nwokolo N; McOwan A; Whitlock G
    Int J STD AIDS; 2015 Jul; 26(8):590-2. PubMed ID: 25122580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating the potential impact of COVID-19-related disruptions on HIV incidence and mortality among men who have sex with men in the United States: a modelling study.
    Mitchell KM; Dimitrov D; Silhol R; Geidelberg L; Moore M; Liu A; Beyrer C; Mayer KH; Baral S; Boily MC
    medRxiv; 2020 Nov; ():. PubMed ID: 33173893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
    Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
    Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is the extent of repeat prescriptions for post-exposure prophylaxis for HIV after sexual exposure among men who have sex with men in the UK?
    Llewellyn C; Martin H; Nixon E
    Sex Health; 2016 Nov; 13(6):595-596. PubMed ID: 27712617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-exposure prophylaxis for human immunodeficiency virus after sexual assault in a Midwestern U.S. emergency department.
    Cherabie JN; Gleason E; Munigala S; Fox B; Trolard A; McCammon C; Hilbert S; Casabar E; Reno H; Liang SY
    Am J Emerg Med; 2021 Nov; 49():117-123. PubMed ID: 34102456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immediate PrEP when accessing PEP: A service evaluation.
    Cockbain B; Whitlock G;
    HIV Med; 2022 Nov; 23(10):1108-1112. PubMed ID: 35352455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-exposure prophylaxis completion and condom use in the context of potential sexual exposure to HIV.
    Gantner P; Allavena C; Duvivier C; Cabie A; Reynes J; Makinson A; Ravaux I; Bregigeon S; Cotte L; Rey D;
    HIV Med; 2020 Aug; 21(7):463-469. PubMed ID: 32558205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UK guideline for the use of HIV post-exposure prophylaxis 2021.
    Cresswell F; Asanati K; Bhagani S; Boffito M; Delpech V; Ellis J; Fox J; Furness L; Kingston M; Mansouri M; Samarawickrama A; Smithson K; Sparrowhawk A; Rafferty P; Roper T; Waters L; Rodger A; Gupta N
    HIV Med; 2022 May; 23(5):494-545. PubMed ID: 35166004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knowledge, attitude and practices of medical and health science students on the antiretroviral based HIV post-exposure prophylaxis in an Ethiopian hospital: an institutional based cross-sectional study.
    Anteneh B; Belachew SA; Endeshaw A; Wubneh ZB; Sarkar BR
    BMC Health Serv Res; 2019 Oct; 19(1):713. PubMed ID: 31638985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sexual health service adaptations to the coronavirus disease 2019 (COVID-19) pandemic in Australia: a nationwide online survey.
    Phillips TR; Fairley CK; Donovan B; Ong JJ; McNulty A; Marshall L; Templeton DJ; Owen L; Ward A; Gunathilake M; Russell D; Langton-Lockton J; Bourne C; Martin S; Chow EPF
    Aust N Z J Public Health; 2021 Dec; 45(6):622-627. PubMed ID: 34473388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.